Introduction
Strokes and their sequelae are a known complication of sickle cell disease [1] , yet far less is known about the neurological complications of rarer hemoglobinopathies. In this report, a case of stroke and moyamoya disease is described in a child with hemoglobin (Hb) Casper, a rare and unstable hemoglobin mutation.
Case Report
A 9-year-old right-handed girl with a history of hemolytic anemia, status post-splenectomy, and previously identified right frontal encephalomalacia presented with a 1-month history of episodic right upper extremity weakness and 'garbled' speech.
Her neurological examination was notable for episodes of nonfluent speech and dysarthria, some right-left confusion, and episodic distal right arm weakness and paresthesias. Her laboratory studies were notable for a macrocytic hemolytic anemia and thrombocytosis, but negative for hypercoagulable, inflammatory, cardiac, infectious, and autoimmune markers. Extensive hematological testing performed for anemia 3 years earlier had revealed an Hb Casper mutation. However, she never returned for follow-up until her current presentation. There was no known family history of strokes, cardiac issues or hematologic abnormalities.
An initial MRI showed multiple foci of impeded diffusion in the left frontal lobe ( fig. 1 vertebral angiography ( fig. 1 f, g ) showed extensive pial-collateral flow over the cerebral convexities from the distal posterior cerebral artery branches with reconstitution of distal MCA territories bilaterally. The patient ultimately underwent bilateral pial synangiosis surgery 2 months later, with no subsequent neurological deficits. More surgically relevant aspects of this patient's treatment have been recently described elsewhere [2] .
Discussion
Hb Casper (Southampton) is the substitution of leucine 106 (G8) of the β-chain by proline, characterized as a de novo mutation in a handful of patients [3] [4] [5] . It consists of anemia, notable hemolysis and splenomegaly, along with recurrent infections with hemolytic crises [6] , which our patient previously experienced. Neurological symptoms have not been previously reported.
After a thorough investigation, we believe that the patient's strokes are due to moyamoya disease, which consists of large-vessel occlusions with extensive vascular collateralization. Given the lack of other causes of moyamoya disease, her hemoglobinopathy is felt to be the most likely etiology. Moyamoya has been extensively described in sickle cell disease [7] . Similar findings were noted in our patient, including leptomeningeal collaterals and increased vascular signal on FLAIR imaging ( fig. 1 c, arrow, 'ivy sign') [8] . Besides sickle cell disease in which occlusion is noted in large vessels possibly due to a proliferative vasculopathy and ultimately resulting in stenosis [9] , evidence of moyamoya disease has been noted in β-thalassemia [10] and several other rare hemolytic anemias including Hb Fairfax [10] and Hb Alesha [11] . Whether transfusion therapy, as used in sickle cell disease, is indicated in patients with moyamoya disease due to other hemoglobinopathies is unknown [10] . If she develops new deficits, transfusion will be considered.
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